tumor

Documents about tumor

• Longitudinal and Multi-Omics Analysis of Metastatic Melanoma Reveals Dynamic Tumor Evolution and Multi-Level Heterogeneity#202406Harvard DASH
• Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes.#9949PubMed
• AO-176 in Multiple Solid Tumor Malignancies#123474ClinicalTrials.gov
• Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers#224603IRIS
• CTにて偶然発見された精巣Leydig細胞腫の1例#189768Kyoto University Research Information Repository
• CTにて偶然発見された精巣Leydig細胞腫の1例#189807Kyoto University Research Information Repository
• 単一施設における性腺外胚細胞腫瘍25例の臨床的検討#189753Kyoto University Research Information Repository
• 単一施設における性腺外胚細胞腫瘍25例の臨床的検討#189792Kyoto University Research Information Repository
• MAX-10181 in Patients With Advanced Solid Tumor#363591ClinicalTrials.gov
• Identification and Evaluation of Circulating Tumor Cells and Tumor Related Rare Cells in Immunotherapy#287554ClinicalTrials.gov
• Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma#178206HAL (France)
• Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction#184742ClinicalTrials.gov
• MAX-10181 Given Orally to Patients With Advanced Solid Tumor#28313ClinicalTrials.gov
• Neoantigen Derived DCs as Cancer Treatment#127578ClinicalTrials.gov
• Infection Prevention Bundle in Brain Tumor Surgery#141036ClinicalTrials.gov
• Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment#143551ClinicalTrials.gov
• Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors#195413ClinicalTrials.gov
• MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers#329576ClinicalTrials.gov
• Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells#143563ClinicalTrials.gov
• Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor#154739ClinicalTrials.gov
• Computational Framework for Acidity-Responsive Regulation in Tumor–Immune Microenvironment Dynamics#187135Zenodo (CERN)
• Transcriptomal and Molecular Characterization of Tumor Associated Monocytes/Macrophages in Human Cancers#162474ClinicalTrials.gov
• Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden#208464ClinicalTrials.gov
• Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy#154672ClinicalTrials.gov
• Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy#321700ClinicalTrials.gov
• The gut microbiota-derived metabolite regulates anti-tumor responses against brain tumor#354303KOASAS: KAIST Open Access Self-Archiving System
• Symbiont reintroduction alters tumor progression and life‐history traits in the tumor‐bearing freshwater cnidarian Hydra oligactis#284366HAL (France)
• Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors#230439ClinicalTrials.gov
• Tumor-microenvironment-modulating microspheres to augment tumor-infiltrating lymphocyte therapy against solid tumors.#315798NCBI PubMed Central
• The gut microbiota-derived metabolite regulates anti-tumor responses against brain tumor#354301KOASAS: KAIST Open Access Self-Archiving System
• A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers#287544ClinicalTrials.gov
• A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors#353291ClinicalTrials.gov
• EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors#268028ClinicalTrials.gov
• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy#4574Europe PMC
• Tumor Microenvironment#321719ClinicalTrials.gov
• A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.#121290ClinicalTrials.gov
• Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors#208426ClinicalTrials.gov
• Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity.#322996NCBI PubMed Central
• Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.#349940ClinicalTrials.gov
• Research progress on the molecular mechanisms of PD-1 and LAG-3 synergy in regulating T cell exhaustion and immunotherapy#4543Europe PMC
• Central dentinogenic ghost cell tumor of the maxilla: a case report with new imaging findings and review of the literature#368435OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Ovarian Cancer Immunology and Immunotherapy: Editorial Note#269354ODU Digital Commons
• Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor#287529ClinicalTrials.gov
• Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges#178213HAL (France)
• Pathology of HPV-associated head and neck carcinomas: Recent data and perspectives for the development of specific tumor markers#218217HAL (France)
• Deep Learning Based Intelligent Tumor Analytics Framework for Quantitative Grading and Analyzing Cancer Metastasis: Case of Lymph Node Breast Cancer#274647IRIS
• On a Tumor Monitoring Equation#371038KFUPM ePrints
• The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy#123452ClinicalTrials.gov
• Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods.#258130NCBI PubMed Central
• A Scalable Framework for Pan-Cancer Tumor Evolution Analysis Enables Transfer of Progression Mechanisms Across Tumor Entities#273195Europe PMC